Wolfgang Plischke

Chief Technology Officer at Bayer AG

Wolfgang Plischke

Wolfgang Plischke

Chief Technology Officer at Bayer AG

Overview
Career Highlights

Bayer Yakuhin Ltd.

RelSci Relationships

1573

Number of Boards

20

Birthday

09/1951 - Stuttgart, Germany

Age

68

Number of Awards

1

Relationships
RelSci Relationships are individuals Wolfgang Plischke likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Bayer AG

Relationship likelihood: Strong

Head, Crop Science Division at Bayer AG

Relationship likelihood: Strong

Chief Financial Officer at ThyssenKrupp AG

Relationship likelihood: Strong

Director, Strategic Relations at Bayer Corporation

Relationship likelihood: Strong

Founder & Chairman at Novalis LifeSciences

Relationship likelihood: Strong

Head of Consumer Health at Bayer AG

Relationship likelihood: Strong

Professional at Novo Nordisk A/S

Relationship likelihood: Strong

President & Chief Executive Officer at Bayer Pharma AG

Relationship likelihood: Strong

Bayer AG

Relationship likelihood: Strong

Professional at Bayer AG

Relationship likelihood: Strong

Paths to Wolfgang Plischke
Potential Connections via
Relationship Science
You
Wolfgang Plischke
Chief Technology Officer at Bayer AG
Education
Undergraduate Degree
Class of 1979

International Business and Economics Master

Career History
Chief Technology Officer
2000 - Current

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen. In fiscal year 2012, Bayer employed 110,500 people and had sales of €39.8 billion. Capital expenditures amounted to €2 billion, R&D expenses to €3 billion.

Vice President
Current
Independent Chairman of the Supervisory Board
Current

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmes on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties. The EVT Innovate develops drug discovery projects, assets and platforms, both internally or through academic collaborations. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, and Charles Weissmann on December 8, 1993 and is headquartered in Hamburg, Germany.

Boards & Committees
Chairman-Supervisory Board
Current

Bayer Technology Services GmbH offers plant management and processing solutions specializing in chemical and pharmaceutical industries. Its solutions encompass project management consulting, asset life cycle management, manufacturing, engineering and processing technology. The company was founded in 2002 and is based in Leverkusen, Germany.

Chairman-Supervisory Board
Current

Bayer Real Estate GmbH, part of Bayer AG, is a German company located in Leverkusen. The firm engages in management of land, buildings and apartments.

Chairman-Supervisory Board
Current

Bayer Innovation GmbH, a subsidiary of Bayer AG, is a company headquartered in Dusseldorf, Germany. The firm conducts creative pharmaceutical research. Detlef Wollweber is the current CEO of the firm.

Trustee
Current
Vice President of the Board
Current

Cefic is a committed partner to EU policymakers, facilitating dialogue with industry and sharing their broad-based expertise. They represent 29,000 large, medium and small chemical companies in Europe, which directly provide 1.2 million jobs and account for 17% of world chemical production. Based in Brussels since their founding in 1972, they interact every day on behalf of their members with international and EU institutions, non-governmental organisations, the international media, and other stakeholders.

Awards & Honors
Ludwig Maximilian University of Munich
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Wolfgang Plischke. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Wolfgang Plischke's profile does not indicate a business or promotional relationship of any kind between RelSci and Wolfgang Plischke.